In 2016, medical professionals across the country scribbled over 14 million prescriptions for medications containing valsartan (Diovan), an antihypertensive drug used to treat high blood pressure and prevent cardiovascular mortality. Two years later, federal investigators detected trace amounts of N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA) in these commonly prescribed medications. Research suggests that both chemicals are potentially carcinogenic and may even lead to gastrointestinal damage, including damage to the kidneys, liver and blood cells.
In 2018, the Food and Drug Administration (FDA) and Mylan Laboratories, Ltd. announced a voluntary recall of over 100 prescription medication drugs containing valsartan. Even so, it's possible that people have been taking these contaminated drugs since 2012. If you or a loved one has suffered the devastating medical complications associated with this defective and dangerous drug, contact the New York City defective and dangerous drug lawyers at Sullivan & Brill, LLP. Our skilled and experienced legal team has a comprehensive understanding of the legalities surrounding this recall. With our help, you can secure damages that account for your existing and projected medical expenses, loss of earning potential, and more.
Call our New York City defective and dangerous drug lawyers at (212) 566-1000 to learn more about your legal options.
While the FDA has strict guidelines when it comes to ensuring consumer safety, it's not unusual for a drug or product to be tainted during the manufacturing process. Consequently, the FDA has completely banned all imports of drug and drug products from Zhejiang Huahai Pharmaceutical, the main manufacturer of valsartan. Unfortunately, millions of people were likely prescribed medications containing dangerous traces of NDMA and NDEA before this recall went into effect. If you've suffered harm from a valsartan product, it's important to contact an experienced and trial-tested legal representative as soon as possible.
The following conditions may be linked to the use of valsartan:
We understand that it can be intimidating to take on a big drug corporation. Fortunately, you aren't alone. At Sullivan & Brill, LLP we can help you navigate each step of this complicated legal process. Our attorneys aren't afraid to stand up against corporate legal teams if it secures a beneficial settlement for our clients. We're also aware of the current mass tort lawsuits being filed against the companies responsible for selling or distributing these dangerous products. By meticulously investigating your situation and researching ongoing cases, we can construct a winning litigation strategy.
The New York City defective and dangerous drug attorneys at Sullivan & Brill, LLP have been litigating product liability and dangerous pharmaceutical cases for over 10 years. If you require legal representation, turn to a team that has your best interests at heart. We work on a contingency fee basis, which means that you don't have to pay us a penny unless you're awarded a beneficial settlement or verdict. Our singular priority is to help our clients obtain advantageous compensation and a necessary sense of closure.
Contact Sullivan & Brill, LLP at (212) 566-1000 to schedule a free consultation.
Copyright © Sullivan Brill Personal Injury Attorneys
